Cargando…

Identification of a Putative Protein Profile Associated with Tamoxifen Therapy Resistance in Breast Cancer

Tamoxifen resistance is a major cause of death in patients with recurrent breast cancer. Current clinical factors can correctly predict therapy response in only half of the treated patients. Identification of proteins that are associated with tamoxifen resistance is a first step toward better respon...

Descripción completa

Detalles Bibliográficos
Autores principales:	Umar, Arzu, Kang, Hyuk, Timmermans, Annemieke M., Look, Maxime P., Meijer-van Gelder, Marion E., den Bakker, Michael A., Jaitly, Navdeep, Martens, John W. M., Luider, Theo M., Foekens, John A., Paša-Tolić, Ljiljana
Formato:	Texto
Lenguaje:	English
Publicado:	American Society for Biochemistry and Molecular Biology 2009
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2690491/ https://www.ncbi.nlm.nih.gov/pubmed/19329653 http://dx.doi.org/10.1074/mcp.M800493-MCP200

Ejemplares similares

Annexin-A1 and caldesmon are associated with resistance to tamoxifen in estrogen receptor positive recurrent breast cancer
por: De Marchi, Tommaso, et al.
Publicado: (2015)

4‐protein signature predicting tamoxifen treatment outcome in recurrent breast cancer
por: De Marchi, Tommaso, et al.
Publicado: (2015)

Phosphoserine aminotransferase 1 is associated to poor outcome on tamoxifen therapy in recurrent breast cancer
por: De Marchi, Tommaso, et al.
Publicado: (2017)

Expression of prostate-specific antigen (PSA) correlates with poor response to tamoxifen therapy in recurrent breast cancer
por: Foekens, J A, et al.
Publicado: (1999)

Proteomics Pipeline for Biomarker Discovery of Laser Capture Microdissected Breast Cancer Tissue
por: Liu, Ning Qing, et al.
Publicado: (2012)

Tumor tissue levels of Tissue Inhibitor of Metalloproteinases-1 (TIMP-1) and outcome following adjuvant chemotherapy in premenopausal lymph node-positive breast cancer patients: A retrospective study
por: Schrohl, Anne-Sofie, et al.
Publicado: (2009)

Prognostic significance of nuclear expression of UMP-CMP kinase in triple negative breast cancer patients
por: Liu, Ning Qing, et al.
Publicado: (2016)

Relevance of BCAR4 in tamoxifen resistance and tumour aggressiveness of human breast cancer
por: Godinho, M F E, et al.
Publicado: (2010)

Proteomic characterization of microdissected breast tissue environment provides a protein‐level overview of malignant transformation
por: Braakman, René B. H., et al.
Publicado: (2017)

The 29.5 kb APOBEC3B Deletion Polymorphism Is Not Associated with Clinical Outcome of Breast Cancer
por: Liu, Jingjing, et al.
Publicado: (2016)

High TWIST1 mRNA expression is associated with poor prognosis in lymph node-negative and estrogen receptor-positive human breast cancer and is co-expressed with stromal as well as ECM related genes
por: Riaz, Muhammad, et al.
Publicado: (2012)

Global proteomic characterization of microdissected estrogen receptor positive breast tumors
por: De Marchi, Tommaso, et al.
Publicado: (2015)

Ferritin Heavy Chain in Triple Negative Breast Cancer: A Favorable Prognostic Marker that Relates to a Cluster of Differentiation 8 Positive (CD8+) Effector T-cell Response
por: Liu, Ning Qing, et al.
Publicado: (2014)

First comprehensive identification of cardiac proteins with putative increased O-GlcNAc levels during pressure overload hypertrophy
por: Zhu, Wei Zhong, et al.
Publicado: (2022)

Higher expression of human kallikrein 10 in breast cancer tissue predicts tamoxifen resistance
por: Luo, L-Y, et al.
Publicado: (2002)

Relationship of PS2 with response to tamoxifen therapy in patients with recurrent breast cancer.
por: Foekens, J. A., et al.
Publicado: (1994)

Elevated expression of polymorphonuclear leukocyte elastase in breast cancer tissue is associated with tamoxifen failure in patients with advanced disease
por: Foekens, J A, et al.
Publicado: (2003)

The DNA cytosine deaminase APOBEC3B promotes tamoxifen resistance in ER-positive breast cancer
por: Law, Emily K., et al.
Publicado: (2016)

Cell-free DNA mutations as biomarkers in breast cancer patients receiving tamoxifen
por: Jansen, Maurice P.H.M., et al.
Publicado: (2016)

Proteomic Profiling of Exosomes Leads to the Identification of Novel Biomarkers for Prostate Cancer
por: Duijvesz, Diederick, et al.
Publicado: (2013)

Comparative Proteome Analysis Revealing an 11-Protein Signature for Aggressive Triple-Negative Breast Cancer
por: Liu, Ning Qing, et al.
Publicado: (2014)

Mitochondrial DNA content in breast cancer: Impact on in vitro and in vivo phenotype and patient prognosis
por: Weerts, Marjolein J.A., et al.
Publicado: (2016)

The Prevalence of CD146 Expression in Breast Cancer Subtypes and Its Relation to Outcome
por: de Kruijff, Ingeborg E., et al.
Publicado: (2018)

Elevated APOBEC3B Correlates with Poor Outcomes for Estrogen-Receptor-Positive Breast Cancers
por: Sieuwerts, Anieta M., et al.
Publicado: (2014)

Gene expression profiles and molecular classification to predict distant metastasis and tamoxifen-resistant breast cancer
por: Klijn, JGM, et al.
Publicado: (2005)

Quantitative Proteomic Profiling of Low-Dose Ionizing Radiation Effects in a Human Skin Model
por: Hengel, Shawna M., et al.
Publicado: (2014)

High miR-26a and low CDC2 levels associate with decreased EZH2 expression and with favorable outcome on tamoxifen in metastatic breast cancer
por: Jansen, M. P. H. M., et al.
Publicado: (2011)

Cathepsin-D in primary breast cancer: prognostic evaluation involving 2810 patients
por: Foekens, J A, et al.
Publicado: (1999)

FRET Imaging of Diatoms Expressing a Biosilica-Localized Ribose Sensor
por: Marshall, Kathryn E., et al.
Publicado: (2012)

Distinct inherited metastasis susceptibility exists for different breast cancer subtypes: a prognosis study
por: Hsieh, Szu-Min, et al.
Publicado: (2009)

Association of microRNA-7 and its binding partner CDR1-AS with the prognosis and prediction of 1(st)-line tamoxifen therapy in breast cancer
por: Uhr, K., et al.
Publicado: (2018)

Mapping Influenza-Induced Posttranslational Modifications on Histones from CD8+ T Cells
por: Rezinciuc, Svetlana, et al.
Publicado: (2020)

A Structure-Based Approach for Mapping Adverse Drug Reactions to the Perturbation of Underlying Biological Pathways
por: Wallach, Izhar, et al.
Publicado: (2010)

Clinical significance of the nuclear receptor co-regulator DC-SCRIPT in breast cancer: an independent retrospective validation study
por: Sieuwerts, Anieta M, et al.
Publicado: (2010)

A Method to Correlate mRNA Expression Datasets Obtained from Fresh Frozen and Formalin-Fixed, Paraffin-Embedded Tissue Samples: A Matter of Thresholds
por: Mustafa, Dana A. M., et al.
Publicado: (2015)

Enhanced top-down characterization of histone post-translational modifications
por: Tian, Zhixin, et al.
Publicado: (2012)

HCMV pUS28 initiates pro-migratory signaling via activation of Pyk2 kinase
por: Vomaske, Jennifer, et al.
Publicado: (2010)

We Are What We Eat: A Stoichiometric and Ecometabolomic Study of Caterpillars Feeding on Two Pine Subspecies of Pinus sylvestris
por: Rivas-Ubach, Albert, et al.
Publicado: (2018)

Higher-order structural characterisation of native proteins and complexes by top-down mass spectrometry
por: Zhou, Mowei, et al.
Publicado: (2020)

Secondary Ion Mass Spectrometry Imaging of Dictyostelium discoideum Aggregation Streams
por: DeBord, John Daniel, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_mibl8irtvekjhdnlb3g55b9scd